The progress that has been made since last winter along with the renegotiated term sheet executing as well as the suitor including "right of first negotiation and first refusal" of other indications for B as they arise,tell me that the suitor is serious about finalizing this deal for UC/UP.

The last term sheet was almost an impossibility because B will have a myriad of indications so how does one put a value on it?

This new term sheet gives the suitor all of B if they want ,just one bite at a time.Makes it easier to value it on a "per indication" basis.

How do you eat an elephant? One bite at a time.

There is our Regeneron business model taking shape.

I wouldn't be surprised if this term sheet was a revision of last August's term sheet for the same suitor.If so,the finalization should likely be far quicker than what is being proposed by our adversaries.

Kelt